Order Saisei Mirai 2nd Generation High Dose GcMAF

Therapy | Treatment

GcMAF (Gc Protein derived
Macrophage Activating Factor)

For the treatment for cancer, HIV and immune system diseases.

Payment informationShipping notesStability of our GcMAF |


Buy GcMAF



If you wish to purchase GcMAF therapy or make an enquiry, please contact us with details of your disease, current treatment and the quantities of Gc-MAF you require.




High Dose GcMAF 2.5 ml multi-dose vials (1500 ng/0.5 ml):

  • Each vial contains 4 doses GcMAF at 0.5 ml/dose with 0.5 ml extra GcMAF per vial. Up to 5 doses GcMAF may be possible to use for each vial.
  • Minimum order of 4 vials.
  • Common quantities - 4, 6, 8, 10 and 12 vials. Other quantities available.
  • Please contact us for pricing.

  • Prices quoted usually include 9000 JPY for shipping and handling by EMS International Express Mail Service worldwide (unless specified otherwise). Cost of shipping by UPS, FedEx, DHL or other shipping companies may need to be calculated for some countries.
  • All GcMAF is manufactured to our patented Second Generation GcMAF production process.
  • Keep vials refrigerated at 2-8 °C for multi-dose use. For long term storage > 1 year, vials maybe be kept frozen and defrosted once for multi-dose use.
  • Please contact us if you require other quantities.
  • By ordering you are considered a patient of Saisei Mirai Clinics. Any personal information provided is treated as confidential.

Payment information

Payment is by wire transfer to our account in Japan. After you confirm your order with us, simply make your wire transfer (see details below). Ideally funds should be sent as Japanese Yen (JPY) or the foreign currency equivalent amount (such as USD or EUR) calculated by your bank, and accept all fees and charges, so that the correct amount is received by us. Once you have made your transfer, please let us know the details of the transfer (such as the account name and bank), and also the products and quantities you are ordering. As soon as we confirm your payment, we will ship your Gc-MAF on the next suitable day depending on the destination. Allow 2-3 business days for payments to be cleared and received by us. If you do not hear anything from us within 7 days, please contact us with details of your payment and order information.


Wire transfer details (International Telegraphic Transfer):

Beneficiary:  Imagin-K Co. Ltd

Beneficiary address:  3-34-8 Okubo-cho, Moriguchi-shi, Osaka 570-0012, Japan

Name of bank:  Sumitomo Mitsui Banking Corporation, Neyagawa Branch

Bank Address:  16-14 Hayako-cho, Neyagawa-shi, Osaka 572-0837, Japan

Account number:  7038812

SWIFT:  SMBCJPJT   (or BIC:  SMBCJPJTXXX)


  • Visit your bank and ask the staff to make a wire transfer from your account. Alternatively, you may be able to do this online via your bank's internet banking service, if you have this set up.
  • Funds should be sent as Japanese Yen (JPY).
  • Note: International Bank Account Number (IBAN) is not used in Japan.
  • Internet banking: Some websites don't allow a dash to be included in the postal code, so if necessary, the dash may be omitted so that the post code/ZIP code becomes one number (e.g., 570-0012 becomes 5700012).
  • Please ensure you provide us with your full name, shipping address and a contact telephone number when you order.


  • GcMAF is a natural immunotherapy product. Variation in GcMAF concentration is due to normal variation between serum samples. Just like Lymphocytes or Natural Killer cells vary in number between people and at any given time, so will the amount of GcMAF which can be produced.
  • Charges for shipping and handling apply to each order. We use EMS International Express Mail Service with tracking information. Each package includes cooling packs to keep Gc-MAF at a stable temperature during shipping. Our second generation GcMAF is strong enough at room temperature to maintain a high level of activity for the days in transit. See more details about the Stability of GcMAF in Serum (PDF) report in Research and references for an experiment done by the University of Tokushima on stability by phagocytic activity of our 2nd generation GcMAF after short-term and long-term storage.
  • We ship GcMAF as a liquid in high quality multi-dose vials. After arrival the vials should be stored in the refrigerator to maintain maximum activity until each injection.

  • Estimated stability of 2nd generation GcMAF

    Activity remains stable at room temperature for a minimum of 2 weeks and at least 1 year refrigerated (2-8 °C).


    Shipping notes

    We use special packaging and cooling packs to keep the temperature of the vials stable. GcMAF is strong enough at room temperature to maintain a high level of activity for the days in transit. See Tests of our GcMAF and Research and references for more details. The GcMAF is expected to reach you in excellent condition with no loss in activity. We ship fresh Gc-MAF as a liquid. After arrival the vials containing GcMAF should be stored refrigerated to maintain maximum activity for multi-dose use.



    If you wish to purchase GcMAF therapy or make an enquiry, please contact us with details of your disease, current treatment and the quantities of Gc-MAF you require.



    News

    Heart Pharmacy website gcmaf.co.jp is now open

    Purchase your Colostrum MAF here using PayPal or credit card.

    Heart Pharmacy website


    2016 Integrative Medical Therapies Conference - Osaka, Japan

    Thank you very much for your participation at the Saisei Mirai 2016 Integrative Medical Therapies conference in Osaka, held on Sunday 13th November 2016.

    2016 Integrative Medical Therapies conference - Osaka, Japan


    Genostics Conference - Sydney, Australia

    24-SEP-2016
    Dr Toshio Inui

    Genostics official website


    Symposium on Integrated Medicine: Electric Fields Therapy & Immunotherapy - Jakarta, Indonesia


    22-JUL-2016
    Dr. Toshio Inui gave a presentation of the electric field therapy and second-generation GcMAF and colostrum MAF at a conference which was held in Jakarta, Indonesia on July 22, 2016.



    International Pharmacy Conference

    14 to 15-JUL-2016
    Dr. Shinichiro Akiyama at International Pharmacy Conference, which was held in the United States Philadelphia, Pennsylvania on July 14 to 15, 2016, the Clinical experience of colostrum derived protein against solid cancer has been announced as the Keynote Speaker.



    New New research papers published by Saisei Mirai in Anticancer Research available online.

    Research paper
    2016 Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis (PDF)
    ANTICANCER RESEARCH 36: 3771-3774 (2016)

    Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis

    Research paper
    2016 Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields (PDF)
    ANTICANCER RESEARCH 36: 3767-3770 (2016)

    Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields Case Report: A Non-small Cell Lung Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Tumor Treating Fields

    Research paper
    2016 Macrophages Exhibit a Large Repertoire of Activation States via Multiple Mechanisms of Macrophage-activating Factors (PDF)
    ANTICANCER RESEARCH 36: 3619-3624 (2016)

    Macrophages Exhibit a Large Repertoire of Activation States via Multiple Mechanisms of Macrophage-activating Factors Macrophages Exhibit a Large Repertoire of Activation States via Multiple Mechanisms of Macrophage-activating Factors Macrophages Exhibit a Large Repertoire of Activation States via Multiple Mechanisms of Macrophage-activating Factors

    New research papers published by Saisei Mirai in Anticancer Research available online.

    New research papers on Oral Colostrum GcMAF for Chronic Fatigue Syndrome (CFS) and serious infection published in Anticancer Research journal.

    Research paper
    2015 Oral Colostrum Macrophage-activating Factor for Serious Infection and Chronic Fatigue Syndrome: Three Case Reports (PDF)
    Anticancer Res August 2015 35 (8) 4545-4549

    Conference presentation - 10th International Congress for Medical Laser Applications, Germany

    13-JUN-2015
    Clinical application of Second Generation GcMAF and oral GcMAF
    Dr Toshio Inui

    Clinical application of Second Generation GcMAF and oral GcMAF
    ISLA website

    Conference presentation - 9th International Congress for Medical Laser Applications, Germany

    29-JUN-2014
    Indications for GcMAF for immunotherapy of cancers and chronic viral and bacterial infections (PDF)

    Dr Toshio Inui

    Dr Toshio Inui Indications for GcMAF for immunotherapy of cancers and chronic viral and bacterial infections

    Conference presentation - The 17th Annual Meeting of The Society of Biotherapeutic Approaches, Fukuoka University

    7-DEC-2013
    Case Report: A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy (PDF), PPT

    Dr Toshio Inui

    Dr Toshio Inui Case Report - A Breast Cancer Patient Treated with GcMAF, Sonodynamic Therapy and Hormone Therapy

    New research papers published by Saisei Mirai in Anticancer Research available online.

    New research papers on GcMAF and integrative cancer immunotherapy treatment written in collaboration with the University of Tokushima, Kanazawa University and Kobe University Graduate School of Medicine researchers and Saisei Mirai published in Anticancer Research journal.

    Research paper
    2013 Degalactosylated/Desialylated Human Serum Containing GcMAF Induces Macrophage Phagocytic Activity and In Vivo Antitumor Activity (PDF)
    Anticancer Res July 2013 33 (7) 2881-2885

    Cancer vaccine therapy - autologous tissue derived tumor vaccine Cancer vaccine therapy - autologous tissue derived tumor vaccine Cancer vaccine therapy - autologous tissue derived tumor vaccine

    Research paper
    2013 Clinical Experience of Integrative Cancer Immunotherapy with GcMAF (PDF)
    Anticancer Res July 2013 33 (7) 2917-2919

    Cancer vaccine therapy - autologous tissue derived tumor vaccine Cancer vaccine therapy - autologous tissue derived tumor vaccine Cancer vaccine therapy - autologous tissue derived tumor vaccine

    Nature Outlook sponsored article

    For more details on GcMAF see our GcMAF page.



    Experiment report of Gc MAF stability assay
    14-JUN-2012 Stability of GcMAF in Serum (PDF)
    H Mukai, Y Uto. Department of Biological Science and Technology, The University of Tokushima.

    Stability of GcMAF in Serum report Stability of GcMAF in Serum report

    The results show that 2nd Generation GcMAF is stable for 1 year at 4 °C, for 14 days at room temperature (around 20 °C), and for 7 days at 40 °C.

    See Research and references for more details on experiments on macrophage phagocytic activity and stability of our GcMAF.


    Collaborations with the University of Tokushima
    We collaborate with GcMAF researchers at the University of Tokushima, Japan in the development of second generation GcMAF. See Research and references for published research papers on Gc-MAF in peer-reviewed scientific journals authored by the University of Tokushima researchers over the last decade. Our research on GcMAF is ongoing and papers are being prepared for publication in collaboration between the University of Tokushima and Saisei Mirai in the next few months.


    University of Tokushima, Institute of Technology and Science, Laboratory Research

    Our research group:


    Imagin-K

    Contact us
    GcMAF
    Treatments and therapies
    Contact us

    Saisei Mirai Clinics
    Kobe Saisei Mirai Clinic
    • Cancer
    • Skin regeneration
    • Skin rejuvenation
    • Anti-aging
    Kobe Saisei Mirai Clinic

    Boeki Center Building
    23rd Floor
    5-1-14 Hamabetori Chuo-ku
    Kobe-shi
    Hyogo-ken 651-0083
    Japan


    Inui Cancer
    Immunotherapy Clinic
    • Cancer
    • Hepatitis
    • Chronic diseases
    Inui Cancer Immunotherapy Clinic

    6-14-17 Kindachou
    Moriguchi-shi
    Osaka 570-0011
    Japan
    TEL: +81 (0)6-6902-5251
    FAX: +81 (0)6-6902-7133

    Inui Cancer Immunotherapy Clinic

    Keihan Clinic
    • Cancer
    • Hepatitis
    • Chronic diseases
    • Anti-aging
    Saisei Mirai Keihan Clinic

    Nature 21 Building
    2nd Floor
    3-34-8 Okubo-cho
    Moriguchi-shi
    Osaka 570-0012
    Japan
    TEL: +81 (0)6-6902-1001


    R Future Cancer Int'l Clinic
    • Cancer
    R Future Cancer Int'l Clinic

    ORE Hiroo Building
    7th Floor
    5-10-26 Minamiazabu
    Minato-ku
    Tokyo-to 106-0047
    Japan


    R Science Clinic
    • Skin regeneration
    • Skin rejuvenation
    • Anti-aging
    R Mirai Clinic

    ORE Hiroo Building
    6th Floor
    5-10-26 Minamiazabu
    Minato-ku
    Tokyo-to 106-0047
    Japan


    Immunotherapy Lab
    • Cell Processing Center
    Immunotherapy Lab

    Nature 21 Building
    3rd Floor
    3-34-8 Okubo-cho
    Moriguchi-shi
    Osaka 570-0012
    Japan